Skip to Main Content

Author Details

Francisco M De La Vega
Stanford University School of Medicine
1991
103
43
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36675105Analysis of Serial Neuroblastoma PDX Passages in Mice Allows the Identification of New Mediators of Neuroblastoma Aggressiveness.Int J Mol Sci2023
37794265The status of the human gene catalogue.Nature2023
37416509A deep-learning-based RNA-seq germline variant caller.Bioinform Adv2023
37231433Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations.Breast Cancer Res2023
36994150The status of the human gene catalogue.ArXiv2023
36540975Session Introduction: Overcoming health disparities in precision medicine.Pac Symp Biocomput2023
35134211Racial and Ethnic Differences in Genomic Profiling of Early Onset Colorectal Cancer.J Natl Cancer Inst2022
35345594A protocol to enrich in undifferentiated cells from neuroblastoma tumor tissue samples and cell lines.STAR Protoc2022
35882841An automated 13.5â¿¿hour system for scalable diagnosis and acute management guidance for genetic diseases.Nat Commun2022
34966181Virtual meetings promise to eliminate geographical and administrative barriers and increase accessibility, diversity and inclusivity.Nat Biotechnol2022
34645491Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases.Genome Med2021
33915777Non-Canonical Kinases and Substrates in Cancer Progression.Cancers (Basel)2021
32161378Integrated genomic characterization of ERBB2/HER2 alterations in invasive breast carcinoma: a focus on unusual FISH groups.Mod Pathol2020
33233777Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation.Cancers (Basel)2020
32793389A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.Cell Discov2020
32179496Response to "High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma".EBioMedicine2020
32109836Corrigendum to 'CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours' [EBioMedicine 49 (2019) 82-95].EBioMedicine2020
30936564An open resource for accurately benchmarking small variant and reference calls.Nat Biotechnol2019
31861671Hypoxia in the Initiation and Progression of Neuroblastoma Tumours.Int J Mol Sci2019
31685444CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.EBioMedicine2019
30899106Author Correction: Best practices for benchmarking germline small-variant calls in human genomes.Nat Biotechnol2019
30858580Best practices for benchmarking germline small-variant calls in human genomes.Nat Biotechnol2019
27875099The RhoB small GTPase in physiology and disease.Small GTPases2018
30591078Polygenic risk scores: a biased prediction?Genome Med2018
29753700Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.Lancet Oncol2018
29354287A robust targeted sequencing approach for low input and variable quality DNA from clinical samples.NPJ Genom Med2018
28035032Using genotype array data to compare multi- and single-sample variant calls and improve variant call sets from deep coverage whole-genome sequencing data.Bioinformatics2017
28223221The atheroma plaque secretome stimulates the mobilization of endothelial progenitor cells ex vivo.J Mol Cell Cardiol2017
29163787Neural crest derived progenitor cells contribute to tumor stroma and aggressiveness in stage 4/M neuroblastoma.Oncotarget2017
27334688Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiation.Sci Rep2016
28881723Association of high microvessel α<sub>v</sub>β<sub>3</sub> and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126.Oncotarget2016
25156663Clinical pertinence metric enables hypothesis-independent genome-phenome analysis for neurologic diagnosis.J Child Neurol2015
26504226Discovery and functional characterization of a neomorphic PTEN mutation.Proc Natl Acad Sci U S A2015
26110529Inexpensive and Highly Reproducible Cloud-Based Variant Calling of 2,535 Human Genomes.PLoS One2015
25630770The Rho GTPase RhoB regulates cadherin expression and epithelial cell-cell interaction.Cell Commun Signal2015
24667040An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge.Genome Biol2014
24771338Nucleosome regulatory dynamics in response to TGFβ.Nucleic Acids Res2014
24874280Joint variant and de novo mutation identification on pedigrees from high-throughput sequencing data.J Comput Biol2014
23171949Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities.Mol Cancer Ther2013
24482902[Study of the expression of neural stem cell markers in neuroblastoma tumor samples and correlation with prognostic factors].Cir Pediatr2013
22135348Low-pass genome-wide sequencing and variant inference using identity-by-descent in an isolated human population.Genetics2012
23040495Population genetic inference from personal genome data: impact of ancestry and admixture on human genomic variation.Am J Hum Genet2012
23148235Cdc42 promotes transendothelial migration of cancer cells through β1 integrin.J Cell Biol2012
22724071RhoB regulates cell migration through altered focal adhesion dynamics.Open Biol2012
21208434Analyses of a set of 128 ancestry informative single-nucleotide polymorphisms in a global set of 119 population samples.Investig Genet2011
21940856An Aboriginal Australian genome reveals separate human dispersals into Asia.Science2011
21576392RhoA and RhoC have distinct roles in migration and invasion by acting through different targets.J Cell Biol2011
21514377Roles of VRK1 as a new player in the control of biological processes required for cell division.Cell Signal2011
21753830Genomics for the world.Nature2011
21325948Global analysis of disease-related DNA sequence variation in 10 healthy individuals: implications for whole genome-based clinical diagnostics.Genet Med2011
  • 1 - 50 of 103

Recommended Authors

Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 10
Tommaso Mazza
Fondazione IRCCS Casa Sollievo della Sofferenza,71013
Career Start Year 2005
Number of shared co-authors 1
Semin Lee
Ulsan National Institute of Science and Technology (UNIST)
Career Start Year 2005
Number of shared co-authors 9
Sophia Derdak
Medical University of Vienna
Career Start Year 2001
Number of shared co-authors 7
Stacey Gabriel
Broad Institute of MIT and Harvard
Career Start Year 2001
Number of shared co-authors 55
Hugues Sicotte
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 7
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 2
Chao Xing
University of Texas Southwestern Medical Center
Career Start Year 1999
Number of shared co-authors 3
Alexandre Montpetit
McGill University and Genome Quebec Innovation Centre
Career Start Year 1998
Number of shared co-authors 33
Biao Li
The Buck Institute for Research on Aging
Career Start Year 1997
Number of shared co-authors 5
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Career Start Year 1997
Number of shared co-authors 5
Steven J M Jones
University of British Columbia
Career Start Year 1995
Number of shared co-authors 59
Unnur Thorsteinsdottir
University of Iceland
Career Start Year 1995
Number of shared co-authors 17
Wilson A Silva
Ribeirao Preto Medical School - University of Sao Paulo
Career Start Year 1994
Number of shared co-authors 1
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 2
Alejandro A Sch??ffer
National Cancer Institute, National Institutes of Health
Career Start Year 1993
Number of shared co-authors 3
Thomas J Hudson
Ontario Institute for Cancer Research
Career Start Year 1991
Number of shared co-authors 31
Aleksandar Milosavljevic
Baylor College of Medicine
Career Start Year 1991
Number of shared co-authors 22
Sean M Grimmond
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 14
Jong-Il Kim
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year 1989
Number of shared co-authors 5
Shrikant Mane
Yale School of Medicine
Career Start Year 1989
Number of shared co-authors 16
Richard A Gibbs
Baylor College of Medicine
Career Start Year 1987
Number of shared co-authors 74
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 10
Jiannis Ragoussis
McGill University
Career Start Year 1986
Number of shared co-authors 20
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Career Start Year 1986
Number of shared co-authors 49
David A Wheeler
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 48
Tatsuhiko Tsunoda
The University of Tokyo
Career Start Year 1984
Number of shared co-authors 12
Richard M Myers
HudsonAlpha Institute for Biotechnology
Career Start Year 1980
Number of shared co-authors 27
Francis S Collins
University of Michigan ann arbor
Career Start Year 1978
Number of shared co-authors 43
Kelly A Frazer
University of California, USA Institute for Genomic Medicine
Career Start Year 1967
Number of shared co-authors 19

Collaborators

Carlos D Bustamante
Stanford University
Co-authored papers 10
Martin G Reese
Fabric Genomics Inc.
Co-authored papers 6
Mark Yandell
University of Utah
Co-authored papers 5
Ana Sevilla
Co-authored papers 5
Len Trigg
Co-authored papers 4
Andrew G Clark
Co-authored papers 4
Birgit Funke
Partners Healthcare Center for Personalized Genetic Medicine
Co-authored papers 3
Marc Salit
Stanford University
Co-authored papers 3
Sorin Istrail
Center for Computational Molecular Biology, Brown University
Co-authored papers 3
Stephen J O'Brien
Co-authored papers 3
Rebecca Truty
Invitae Corporation
Co-authored papers 3
Heather E Peckham
Co-authored papers 3
Suyash Shringarpure
23andMe Inc.
Co-authored papers 3
Justin M Zook
National Institute of Standards and Technology
Co-authored papers 3
Catherine A Brownstein
Harvard Medical School.
Co-authored papers 2
Zivana Tezak
Center for Devices and Radiological Health
Co-authored papers 2
Jeffrey M Kidd
University of Michigan Medical School ann arbor
Co-authored papers 2
Peter Krusche
Novartis Pharma AG
Co-authored papers 2
Vineet Bafna
University of California San Diego
Co-authored papers 2
Stefan Schreiber
Co-authored papers 2
Ashok Veeraraghavan
Rice University
Co-authored papers 2
Donald L Durden
Atrium Health-Levine Cancer Institute
Co-authored papers 2
George Asimenos
Co-authored papers 2
Barry Moore
Utah Center for Genetic Discovery, University of Utah
Co-authored papers 2
Stephen F Kingsmore
Rady Children's Institute for Genomic Medicine
Co-authored papers 2
Kim D Pruitt
National Center for Biotechnology Information, National Institutes of Health
Co-authored papers 2
Kathleen C Barnes
Co-authored papers 2
Andre Franke
Institute of Clinical Molecular Biology, Kiel University
Co-authored papers 2
Rasmus Nielsen
Co-authored papers 2
Terence D Murphy
National Center for Biotechnology Information, National Institutes of Health
Co-authored papers 2
Release 1.2